NCT05940272
Recruiting
N/A
Evaluation of a Communication Intervention (Hematolo-GIST) for Large B-Cell Lymphoma Providers
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Lymphoma, B-Cell
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrollment
- 48
- Locations
- 2
- Primary Endpoint
- Feasibility of the Hematolo-GIST intervention among hematologists and participants
- Status
- Recruiting
- Last Updated
- 6 months ago
Overview
Brief Summary
The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients about their lymphoma diagnosis and advance care planning.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Currently a an MSK provider caring for patients with DLBCL (including DLBCL-transformed follicular lymphoma (TFL) and primary mediastinal B-cell lymphoma (PMBCL) which are histologically similar and treated as large-cell lymphoma)
- •Per medical record, is currently being treated by a provider who is participating in this study (for the purposes of this study, "treating provider" will be defined as any provider who provides care related to the patient's lymphoma diagnosis)
- •Per medical record, has a diagnosis of DLBCL including DLBCL-transformed follicular lymphoma (TFL) and primary mediastinal B-cell lymphoma (PMBCL) which are histologically similar and clinically treated as large-cell lymphoma
- •Per medical record, relapse/ refractory disease within 12 months of 4 cycles of first line therapy OR relapse after 2 cycles of later line therapy or or autologous stem cell transplant (ASCT)
- •Self-identify as Black and/or White
- •Per medical record, 18 years of age or older
- •Per self-report, fluent in English\*\*
- •Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify English fluency necessary for participation in the study:
- •How well do you speak English? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
- •What is your preferred language for healthcare? (must respond English)
Exclusion Criteria
- •Per self-report, planning to leave the cancer center in the next 12 months
- •Cognitively impaired as demonstrated by (Blessed Orientation- Memory- Concentration (BOMC) score of ≥ 11
- •Per research staff judgment and/or self-report, too ill or weak to complete study procedures
- •Per medical record or self-report, receiving hospice care at the time of enrollment
Outcomes
Primary Outcomes
Feasibility of the Hematolo-GIST intervention among hematologists and participants
Time Frame: Up to 1 year
Feasbility is defined as ≥70% of screened eligible hematologists and participants enrolling in the study and ≥80% of hematologists learning the approach
Study Sites (2)
Loading locations...
Similar Trials
Completed
N/A
A Communication Enhancing Intervention to Improve Patients' Perception of Physiotherapy ConsultationsCommunicationNCT04452903Ariel University558
Completed
N/A
Family Support Intervention in Intensive Care Units (The Four Supports Study)Physician-Family Communication in Intensive Care UnitsSurrogate Decision-making for Critically Ill PatientsNCT01107704University of Pittsburgh159
Completed
N/A
On-site Supportive Communication Training in Doctor-patient CommunicationCommunication ProgramsCommunication, ManualCommunication ResearchOncologyDoctor Patient RelationJob StressBurnoutSatisfaction, PatientEfficacy, SelfNCT05842083Vejle Hospital89
Completed
N/A
Communication Training for Caregivers In Advanced Care PlanningPrimary Malignant Brain TumorsAdvanced Care PlanningNCT04171895Memorial Sloan Kettering Cancer Center49
Completed
N/A
Communication Intervention Physical ActivityPhysical ActivityNCT01419093University of Rochester325